id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
oHlWiOqGEemMuGfxqOrlZw,3NabqAPM,https://europepmc.org/articles/PMC5026174/, Anxiety,on the Hamilton Rating Scale for,) are normally distributed with ,TextQuoteSelector,TextPositionSelector,78546,78554,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-09T11:19:14.748472+00:00
nbyNhuqEEemrrkd-LFmW7A,3NabqAPM,https://europepmc.org/articles/PMC5026174/,MLE,"o stages for the control is Z
0,","=t
0
X
0+(1 − t
0)Y
0 and simila",TextQuoteSelector,TextPositionSelector,20073,20076,WT_GP,yes,[WT_GP][ALL],,acct:vaishnavijpai@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-09T11:04:51.255316+00:00
hTzC1OqFEem34Kt7EhZnZQ,3NabqAPM,https://europepmc.org/articles/PMC5026174/,CHN,"mance of the Kimani et al. (D
1,","), naïve (D
1,MLE) and stage 2 (",TextQuoteSelector,TextPositionSelector,58292,58295,WT_GP,no,[WT_GP],,acct:vaishnavijpai@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-09T11:11:19.634051+00:00
evGgiu_iEempA4N3JVQwfA,3NabqAPM,https://europepmc.org/articles/PMC5026174/,generalised anxiety disorder, a placebo for the treatment of ,. We assume that the outcomes (t,TextQuoteSelector,TextPositionSelector,77199,77227,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-16T06:59:21.306630+00:00
eXlVluqCEemCGFPjQ_u-PQ,3NabqAPM,https://europepmc.org/articles/PMC5026174/, colorectal cancer,on 2 and treatment selection for, 3. Regulatory guidance dealing ,TextQuoteSelector,TextPositionSelector,8727,8745,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-09T10:49:31.326379+00:00
cGPOIu_iEemDDdPnCuz1ug,3NabqAPM,https://europepmc.org/articles/PMC5026174/,chronic obstructive pulmonary disorder,tice include dose selection for ," 1, acute myocardial infarction ",TextQuoteSelector,TextPositionSelector,8628,8666,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-16T06:59:03.596236+00:00
b6zOWOqCEemXaee0OhQoww,3NabqAPM,https://europepmc.org/articles/PMC5026174/,acute myocardial infarction,"structive pulmonary disorder 1, ", 2 and treatment selection for c,TextQuoteSelector,TextPositionSelector,8670,8697,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,Unbiased estimation in seamless phase II/III trials with unequal treatment effect variances and hypothesis-driven selection rules.,2019-10-09T10:49:14.989926+00:00
